Fundraising Fox

Biotech Late Stage Investors & VC Firms

652 firms in this list, with a median first check of $1M. 131 of them lead rounds. Generated from verified public data and updated continuously.

Excel Venture Management
BostonSeed–Late Stage$1M – $5M
7 people
Seroba Life Sciences
DublinSeed–Late Stage$540K – $7.6M
13 people
Georgian
Toronto, OntarioSeries B–Late Stage$25M – $100M
12 people
Sodero
NantesSeed–Late Stage$162K – $5.4M
16 people
IDG Capital
Hong KongPre-Seed–Late Stage$3M – $200M
6 people
SIB Innovations- und Beteiligungsgesellschaft
DresdenSeed–Late Stage$54K – $10.8M
6 people
MVM Life Science Partners
LondonSeed–Late Stage$20M – $100M
11 people
Tin Alley Ventures
MelbournePre-Seed–Late Stage
14 people
Ally Bridge Group
New YorkSeed–Late Stage
7 people
SABIC Ventures
SittardSeed–Late Stage$500K – $20M
10 people
Sutter Hill Ventures
Palo AltoSeed–Late Stage$100K – $5M
7 people
3B Future Health Fund
MonacoPre-Seed–Late Stage$12M
12 people
New Rhein Healthcare Investors, LLC
PhiladelphiaSeries A–Late Stage
15 people
Gilead Sciences
Foster CitySeries B–Late Stage
17 people
ISA Ventures
Cedar RapidsPre-Seed–Late Stage$25K – $1M
4 people
Fraser
BerlinSeed–Late Stage
15 people
Industrial Technology Investment Corporation
TaipeiSeed–Late Stage$1.9M – $227M
Scion Life Sciences
New YorkPre-Seed–Late Stage$1K – $60M
12 people
Birchmere Ventures
PittsburghSeed–Late Stage$500K – $5M
5 people
GEOC
ShanghaiSeed–Late Stage$3M – $10M
11 people
Gimv
AntwerpGrowth–Late Stage$21M – $430M
11 people
Level One Fund
MiamiSeed–Late Stage
5 people
Pivotal Life Sciences
San FranciscoSeed–Late Stage
14 people
Fine Structures Ventures
CambridgePre-Seed–Late Stage
10 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.